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Abstract
Background: Pharmaceutical pictograms have been designed to help communicate medication in-
structions to patients. Pictograms used within a patient counseling service can significantly improve 
medication compliance and adherence. The study aimed to assess the improvement of adherence to 
therapy with the use of pictogram intervention in comparison to standard pharmacy practice in com-
munity pharmacies. 
Methods: Pictograms informing about the proper way of using metoprolol prolonged release tablets 
were designed to be used on the packages of the drug in community pharmacies. Pharmacies belonging 
to a pharmacy practice-based research network were randomly assigned to a group using pictograms 
when dispensing the drug or one following their normal practice. At the first visit, all patients answered 
a structured questionnaire about their medication behavior in the preceding 7 days. The same questions 
were asked 4 weeks later to follow-up treatment adherence change and compare patients from pictogram 
group and standard practice group. Descriptive statistics was used to analyze the data, and the McNe-
mar test was used to compare categorical data at baseline and follow-up. 
Results: Of a total of 253 patients screened, 117 and 104 patients completed the study in the standard 
practice and pictogram groups, respectively. The use of pictograms significantly improved medication 
adherence in the following areas: not omitting doses (p < 0.0001), not crushing tablets (p = 0.004), 
number of tablets/day (p = 0.49), and time of use (p = 0.001), compared to the standard practice group. 
Conclusions: Our results suggest that pictograms are effective in conveying messages about the proper 
way of using medications, and they increase treatment adherence, in comparison to standard dispensing 
practice. (Cardiol J 20XX; XX, X: xx–xx)
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To date, many studies have addressed the 
problem of lack of adherence in patients diagnosed 
with chronic diseases. Due to the high prevalence 
and burden of cardiovascular diseases, adherence 
to prescribed treatment is considered among the 
most critical strategies contributing to improving 
health outcomes [1, 2]. Of the many factors affect-
ing medication adherence, health care providers’ 
factors are highlighted in particular [2]. Improv-
ing communication with the patient, patients’ 
education, and increasing patient involvement 
can significantly improve medication adherence. 
Pharmacists’ counseling is especially emphasized 
in this area [3]. Pharmacists play a key role in 
handling prescriptions, and by direct contact with 
patients just before the use of the drug, they have 
great potential to encourage patient compliance [4]. 
Good compliance and adherence improve health-
related outcomes in many conditions [5]. On the 
other hand, poor medication adherence is associ-
ated with higher mortality and a greater risk of 
hospitalization [6].
Pharmaceutical pictograms as a supplement 
to pharmacy counseling are considered an effec-
tive tool facilitating the patient’s understanding 
of the information provided [1, 7]. Pictograms are 
defined as visual images used in health information 
materials [8]. These types of drawings graphically 
represent instructions for the correct use and stor-
age of medicines [7]. Pictograms enable patients to 
understand the instructions on how to use medi-
cines, which is especially important in the context 
of health literacy. Pictograms can significantly influ-
ence the proper use of drugs among patients with 
low health literacy [9]. Thus, including pictograms 
in patient counseling could reduce the frequency 
of medication dosing errors. Moreover, pictograms 
in combination with a leaflet attached to the drug 
increase the patient’s attention, remembering and 
recalling the rules of taking the drug [10]. Signifi-
cantly, pictograms are culturally neutral, making 
them understandable regardless of language, also 
for people who cannot fully understand printed tex-
tual medication information [9]. Although there are 
many publications on pictograms in the literature, 
data about the utilization of pharmaceutical picto-
grams in a community pharmacy setting is limited. 
Most studies focus on design, comprehensiveness, 
and validation of different pictograms. High-quality 
studies are needed to support the routine use of any 
pictogram-based materials in routine practice. This 
study presents the results of the utilization of phar-
maceutical pictograms in a community pharmacy 
setting. The study aimed to compare changes in 
adherence to treatment with metoprolol prolonged 
release (PR) in groups of patients who were/were 




This was a multicenter, prospective study 
with a control arm. The study was approved by the 
institutional review board of Collegium Medicum 
in Bydgoszcz, Poland. Patients’ participation in 
the study was voluntary. All the patients provided 
written informed consent. 
Patients were eligible for enrollment in the 
study if they were ≥ 18 years old, had a prescription 
of metoprolol PR tablets, had been using the drug 
once daily for at least 3 months, and signed an in-
formed consent form agreeing to follow-up contact. 
Metoprolol, a beta-blocking agent, belongs 
to the most common drugs used in the treatment 
of cardiovascular diseases. Patients who had just 
started PR metoprolol therapy, had used imme-
diate-release metoprolol, or had been prescribed 
a different dosage regimen than once daily were 
excluded from our study. At a 1:1 ratio between 
groups, levels of type I error 0.05, and type II er-
ror 0.2 the study required 93 patients per group. 
However, these hypothetical assumptions were not 
reflected in the study results. 
The study was conducted in Polish communi-
ty pharmacies belonging to the Farenta Research 
pharmacy practice-based research network. Phar-
macies were randomly assigned in a 1:1 ratio to 
dispense the products together with 3 pictograms 
placed on an external package showing how to use 
the medicine correctly, or in line with standard 
pharmacy practice (control group, without any pic-
tograms). Pharmacies (n = 50) were randomized 
to pictogram or standard practice groups using 
a random sequence generator from www.random.
org. The study was based on 2 interviews: an 
initial interview conducted during dispensation 
and a second interview performed no more than 
30 days after first one (Fig. 1). At pharmacies 
randomized to the pictogram group, each patient 
received with the drug a set of 3 pharmaceuti-
cal pictograms with the following instructions: 
Take 1 tablet in the morning, do not crush the 
tablet, and swallow the tablet with water (Fig. 2). 
All pictograms were validated, as described ear-
lier [11]. The dimension of each pictogram was 
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30 × 30 mm (Fig. 2). Medical information con-
veyed by pictograms was consistent with the 
information in the local summaries of product 
characteristics and aligned with medication plans 
of patients. As recommended by the physician, 
the correct behavior was as follows: taking the 
medicine every day, taking one tablet once a 
day in the morning, not crushing/not chewing 
the tablet, swallowing the tablet with water. At 
pharmacies randomized to the standard practice, 
group patients obtained the drug without picto-
grams. The dispensation was ongoing according 
to the individual practice of pharmacists and not 
influenced by the study team. 
Standard practice Pictogram group




• At the pharmacy or by phone
• Short questions about the course of therapy in the last
   7 days — assessment of therapeutic adherence after the 
   observation period
• At the pharmacy or by phone
• Short questions about the course of therapy in the last 
    7 days — assessment of therapeutic adherence after the 
    observation period
• 30 days (duration of drug use with metoprolol) • 30 days (duration of drug use with metoprolol)
• At the pharmacy
• Patient characteristics (age, gender)
• Information about the drug (drug name, dose, number of tablets 
    in the package, number of prescribed drug packages)
• Survey on therapeutic adherence in the last 7 days prior 
    to the interview
• Use of pharmaceutical pictograms
• At the pharmacy
• Patient characteristics (age, gender)
• Information about the drug (drug name, dose, number of tablets
   in the package, number of prescribed drug packages)
• Survey on therapeutic adherence in the last 7 days prior 
    to the interview
• Standard of pharmacy practice
Figure 1. The use of pharmaceutical pictograms in the course of therapy with metoprolol prolonged-release tablets 
— the intervention chart.
One tablet in the morning Take tablet with water�on�t�  crush
86.5% patients considered pictograms as very supportive.
The NPS was 75.2% in the control group and 90.4% in the pictogram group
Figure 2. The set of pictograms used in the study; NPS — net promoter score.
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Data acquisition
The first study interview was conducted dur-
ing the initial visit at the pharmacy. We gave the 
same questionnaires to both groups. To allow us to 
compare the results from both interviews, during 
the first interview each patient received a unique 
identifier. The interviews were conducted by the 
pharmacy employee dispensing the medicines.
The questions asked in the first interview in-
cluded sociodemographic information and behavior 
regarding use of metoprolol PR tablets in the last 
7 days. Questions were related to the following 
dimensions of adherence: omitting doses, time of 
drug use, a number of tablets taken, dosing frequen-
cy, crushing/chewing tablets, and taking them with 
water (these 6 dimensions are understood as full 
adherence). The Brief Medication Questionnaire 
(BMQ) inspired the design of the questions [5]. 
The questions were adapted to assess outcomes 
influenced by pictogram messages. The scoring 
system was similar to the BMQ. The scales with 
multiple choices graduating the patient’s adherence 
behavior were used to allow patients to indicate 
even small deviations from the target way of the 
use of the drug; however, the analysis was con-
servative, and the only full adherence to therapy 
was considered as a positive outcome. 
The questions used in the study and their 
interpretation are available in Supplementary 
Materials. The second interview was performed 
1 month after the first visit and included the same 
questions as in the earlier survey about adherence 
behavior in the preceding 7 days. Also, patients were 
asked to evaluate medical information received in 
the community pharmacy on a scale from 1 to 10, 
where 1 = very bad and 10 = very good. The data 
were recorded electronically by interviewing the 
employees of the participating pharmacies.
Endpoints
The primary outcome measures of the study 
included a change from the first to the second visit 
in the percentage of patients fully adherent to the 
main messages conveyed by the 3 pictograms: not 
omitting doses, not crushing tablets, swallowing 
tablets with water. The secondary endpoint was 
a change in the percentage of patients declaring 
the use of the correct number of individual doses 
during the day, the right number of tablets per dose, 
and taking the drug in the morning.
Data analysis
All categorical data were expressed as pro-
portions, and continuous data were expressed as 
mean and standard deviation (SD). Descriptive 
analysis was conducted to present the results at 
baseline and follow‐up, assessing the primary and 
secondary outcome measures. Patients’ declara-
tions in the survey were classified as indicating 
full adherence (answers indicating proper behavior) 
or non-adherence (answers indicating any other 
behavior than the proper one or ‘do not know’). 
The McNemar test was used to compare categori-
cal data at baseline and follow-up in both groups. 
Intention to treat analysis was followed, and 
a probability value of < 0.05 was considered statis-
tically significant for all analyses. Possible changes 
from the first visit to the second visit included the 
following: no change in adherence, improvement, 
and worsening of adherence. Logistic regression 
was used to calculate the odds of improvement or 
worsening adherence in every studied dimension 
of adherence for the patients of each group.
The net promoter score (NPS) was used to 
examine the patients’ opinions about medical 
information received at a pharmacy [12]. Patients 
who evaluated medical information as 9 or 10 points 
were classified as advocates. The group of patients 
who responded 7–8 were classified as indifferent, 
and re the respondents who evaluated the infor-
mation received as 1–6 points were classified as 
critical of the provided information. 
Results
Patient disposition and characteristics
The data were collected between January and 
March 2017, and in total 253 patients participated 
in the first interview. The number of screened 
patients is unknown because pharmacists did not 
record patients refusing to participate or ineligible 
to participate. The data of 32 patients were not 
included in the analysis because they were lost to 
follow-up (n = 13), provided incomplete data in the 
first interview (n = 12), used metoprolol immediate 
release (n = 2), were dosed differently than accord-
ing to the inclusion criteria (n = 3), or misconduct 
was detected (n = 2). The complete data from 117 
patients in the standard practice group and 104 pa-
tients in the pictogram group were included in the 
analysis. The baseline characteristics by treatment 
group are presented in Table 1. The patient sample 
was 59% female. Mean age ± SD of patients was 
65.2 ± 13.0 years. The sample included patients 
self-reporting use of metoprolol for hypertension 
(51%), cardiac arrhythmias (29%), prophylactic 
treatment following myocardial infarction (7%), 
angina (5%), and unknown/undeclared reasons (7%).
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The practical effectiveness of pictograms
At baseline, 74 (63.2%) patients in the stand-
ard practice group and 70 (67.3%) patients in the 
pharmaceutical pictograms group had ≥ 1 problem 
in any of the analyzed adherence dimensions. At the 
follow-up, the number of non-adherent patients re-
mained stable in the standard group (n = 76, 65.0%) 
and decreased in the pictogram group (n = 58, 
55.8%), p = 0.1636. Figure 3 presents changes in 
percentages of patients fully adherent in each of 
the 6 analyzed dimensions of adherence at baseline 
and follow-up. In the pictogram group an increase 
in the number of patients with full adherence was 
more common than in the standard practice group. 
The percentage of patients not omitting doses 
increased in the pictogram group from 67.3% to 
88.5% (an increase of 31.5%, p < 0.0001). In the 
standard practice group the percentage of patients 
not omitting doses remained stable (from 77.8% 
to 75.2%; p = 0.8679). At the follow-up, 98.1% of 
patients in the pictogram group were not crushing 
tablets, compared to 81.7% at baseline (increase 
by 20.07%, p = 0.004). In the standard practice 
group, the percentages of patients not crushing 
tablets at baseline and follow-up did not change 
(85.5% vs. 85.5%, p = 0.647). Neither pictograms 
nor standard practice improved significantly for 
the swallowing tablets with water behavior (an 
increase from 45.2% to 52.9% of patients in the 
pictogram group, p = 0.322, and a decrease from 
Figure 3. The percentage of patients fully adherent (proper therapeutic behavior) for each tested adherence domain 
in the standard practice and pictogram groups at baseline and follow-up.
Table 1. Characteristics of the study population.
Routine pharmacy practice  
(n = 117)
Pharmaceutical pictograms  
(n = 104)
Age, median (range) [years] 67 (31–94) 64 (30–91) 
Woman 74 (63.2%) 58 (55.8%) 
Different drugs used by patients:
Missing 1 (0.9%) 0 (0%)
1 drug 5 (4.3%) 5 (4.8%) 
2 drugs 15 (12.8%) 11 (10.6%) 
3 drugs 25 (21.4%) 17 (16.3%) 
≥ 4 drugs 71 (60.7%) 71 (71.2%)
Indication for use of metoprolol:
Hypertension 60 (51.3%) 52 (50.0%)
Cardiac arrythmias 40 (34.2%) 25 (24.0%)
Prophylactic after myocardial infarction 6 (5.1%) 10 (9.6%)
Angina pectoris 5 (4.3%) 7 (6.7%)





























Not crushing tablets Not crushing tablets*
Taking with water Taking with water
*p < 0.05
Daytime of use Daytime of use*
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65.8% to 57.2% of patients in the standard practice 
group, p = 0.121; Fig. 3). 
Pictograms improved adherence in all sec-
ondary endpoints. In the pictogram group the 
percentage of patients using metoprolol once daily 
was 89.4% at baseline and 98.1% at follow-up (an 
increase of 9.73%, p = 0.004). However, a similar 
improvement was also observed in the standard 
practice group (an increase of 7.43%, p = 0.021; 
Fig. 3). Pictograms significantly increased the num-
ber of patients using 1 tablet per day in line with 
a defined treatment plan from 83.6% to 92.3% (an 
increase of 10.27%, p = 0.049). The improvement 
was not significant in the standard practice group 
(p =0.359; Fig. 3). Finally, pictograms increased the 
percentage of patients using the drug in the morn-
ing from 71.1% at baseline to 92.3% at follow-up 
(an increase of 29.63%, p = 0.0001), but this was 
not the case in the standard practice group (p = 1). 
Patients’ opinions about pharmaceutical 
pictograms
The NPS was 75.2% in the control group and 
90.4% in the pictogram group. The vast majority of 
patients (86.5%; n = 90) who obtained pictograms 
identified them as very supportive. The mean score 
± SD in the pictogram group was 9.58 ± 0.69 and 
in the control group 9.24 ± 1.30 (p = 0.0129).
Discussion
This study provides the first comparative evi-
dence that the use of pharmaceutical pictograms 
improves adherence to recommended drug therapy 
in routine pharmacy practice. Improvement of 
adherence was associated with a substantial reduc-
tion in the number of patients who missed drug 
doses. Importantly, pictograms have also increased 
awareness and knowledge about not crushing tablet 
medication, which has clinically relevant implica-
tions in terms of treatment effectiveness. Further-
more, patients who were using pictograms more 
often changed the time of taking the drug to the 
morning, in comparison to the standard practice. 
Of all these areas, only an improvement in dosing 
frequency was observed in the group of patients 
with standard practice.
The only domain of adherence that remained 
unchanged by pictogram use was taking tablets 
with water (as was recommended by the third 
pictogram — take a tablet with water). Because 
the use of tablets with water was the most compro-
mised dimension of adherence studied, improve-
ment of this behavior requires additional studies. 
In Poland, every package insert of metoprolol PR 
provides information about the required liquid vol-
ume recommended to assure effects (the PR form 
of metoprolol should be used in the morning, with 
a minimum half a glass of water, and it cannot be 
crushed). The pictogram highlighted this informa-
tion; however, an improvement was not observed, 
and many patients swallowed medicines without 
or with not enough liquid. 
Non-adherence to recommended therapy can 
lead to ineffectiveness as well as the manifestation 
of unintended adverse reactions [13, 14]. Taking 
a PR formulation requires specific patient behavior 
and should be considered an important matter for 
both physicians and pharmacists [15, 16]. At the 
first interview over 10% of patients from both 
groups crushed the tablets and over 40% of partici-
pants only sometimes swallowed the tablets with 
water. This observation indicates that information 
received from physicians and pharmacists may be 
insufficient for the correct use of medications. 
Strategies to improve medication adherence 
in clinical practice are necessary, given the con-
sequences of medication misuse [6]. Pharmacists, 
who provide pharmaceutical counseling, play a vital 
role in this respect [17–19]. The literature indicates 
many advantages of patient counseling; among 
others, patients become aware of the importance 
of therapy, understand doctors’ recommendations, 
become active participants in the treatment pro-
cess, and thus better follow the treatment recom-
mendations [20].
Patients who received pictograms were able to 
favorably change their behavior, in contrast to those 
who were not using pictograms. This is particularly 
evident with omitting doses, crushing tablets, tak-
ing the right dose with the right frequency, and at 
the correct time of day. Finally, the pictograms were 
well accepted by the vast majority of participants, 
which can be understood as a good prognosis for 
this technology in the future.
Pictograms contribute to a better understand-
ing of the drug’s information, especially for the el-
derly or patients with low health literacy [9]. In our 
study, the patients’ median age was 67 years in the 
standard pharmacy practice group and 64 years for 
patients in the pictogram group. Moreover, most of 
the patients in both groups were taking more than 
4 drugs. For this reason, adherence to therapy for 
these groups of patients is particularly important.
The use of pictograms should be classified as 
a behavioral technique aimed at changing patient 
behavior by constantly reminding the patient of 
proper medication usage. Despite the long history 
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of using pictograms, their effectiveness is still 
a matter of controversy, particularly due to the risk 
of misunderstanding the pictogram [21–23]. Yin et 
al. [24] conducted a high-quality randomized study 
and that showed that pictogram-based interven-
tion decreased the rate of dosing errors among 
caregivers whose children were treated at an urban 
pediatric emergency department. Similarly, a study 
from Malaysia proved the positive role of picto-
grams in improving the quality of use of oral liquid 
medicines. Another study suggests that pictograms 
significantly increased dosing accuracy [25]. The 
results of a recently published analysis of 771 
studies aiming to improve therapeutic adherence 
showed that healthcare professionals should focus 
more on behavioral interventions, especially those 
based on the development of drug use habits, than 
on cognitive strategies to change the knowledge 
and beliefs of patients [26].
Although our study only refers to one product 
(metoprolol), the positive results obtained may be 
an incentive to extend the use of pictograms to 
other drugs used in cardiac diseases. Undoubtedly, 
all pictograms should be designed carefully and 
tested before their implementation to routine prac-
tice [10]. Moreover, pictograms need to be adjusted 
to local requirements, both formally determined 
by local summaries of products characteristics 
and social determinates, which may significantly 
improve understanding and acceptance levels [19]. 
For clarity, pictograms should be supplemented by 
a clear and simple oral statement provided by 
healthcare professionals [27]. It is worth mention-
ing that among illiterate populations, verbal expla-
nations are indispensable, and in many clinical sce-
narios they are crucial to effective comprehension 
of drug-related information conveyed in pictograms 
[28]. While our study indicates that pictograms 
exert a substantial impact on patient behaviors 
and therapeutic adherence, we were not able to 
rule out the potential bias related to the study 
methods. Randomization of pharmacies instead of 
patients would affect the objectivity of findings. 
Moreover, the study was conducted in community 
pharmacies belonging to Farenta Research. These 
pharmacies, relying on the pharmacy standards, 
can provide patients with a better quality of care, 
which may affect the obtained results. The self-
reported medication adherence measures used in 
the study can provide valuable information despite 
their limitations. Patients may tend to evaluate 
their adherence better than it really is. Thus, the 
used questionnaire offered many options to ex-
press the level of adherence, but the data analysis 
was conservative. It was assumed that only total 
adherence was considered as a positive outcome, 
and all other options as non-adherence. The change 
from non-adherence to partial adherence was not 
considered as an improvement. 
Conclusions
Based on these results, pictograms can be 
an effective tool dedicated to improving patient 
adherence. Pictograms were accepted by patients 
and effectively changed most of their inappropriate 
behaviors. Our study certainly confirmed that pic-
tograms significantly improve patients’ compliance, 
particularly in the areas of non-omitted drug doses 
and indications not to crush tablets. Importantly, 
an improvement in compliance in this respect in 
the group of patients with standard practice was 
not observed. Further randomized clinical studies 
aimed at the evaluation of long-term effectiveness 
of pictograms are strongly warranted. Further clini-
cal studies should also focus on health care provid-
ers’ perception of pictograms and how pictograms 
influence regular work in community pharmacies. 
This type of research may improve the transition 
pictograms from research to routine settings.
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